James Woodruff Lillie sold $513K of MapLight Therapeutics (MPLT)

Executed Jul 15, disclosed Jul 18, 2 days later.

Value, as filed

$513K

13,928 sh across 3 lots

Executed

Jul 15

the trade date, as filed

Disclosed

Jul 18

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

James Woodruff Lillie Chief Scientific Officer profile →

James Woodruff Lillie (Chief Scientific Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $1.4M of MPLT (49,719 sh across 5 lots, as filed), executed May 4.

The name

MPLT

MapLight Therapeutics, Inc. MPLT · Healthcare · 30 filings in 24 months ticker →

Healthcare · MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by James Woodruff Lillie in MPLT

MPLTSALE MapLight Therapeutics, Inc. $277K
22,082 sh × $12.54
Exec Aug 3
Filed Aug 4 · 8:39 PM ET MPLTSALE MapLight Therapeutics, Inc. $1.4M
49,719 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET